BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26719529)

  • 1. Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.
    Raynal NJ; Lee JT; Wang Y; Beaudry A; Madireddi P; Garriga J; Malouf GG; Dumont S; Dettman EJ; Gharibyan V; Ahmed S; Chung W; Childers WE; Abou-Gharbia M; Henry RA; Andrews AJ; Jelinek J; Cui Y; Baylin SB; Gill DL; Issa JP
    Cancer Res; 2016 Mar; 76(6):1494-505. PubMed ID: 26719529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.
    Raynal NJ; Da Costa EM; Lee JT; Gharibyan V; Ahmed S; Zhang H; Sato T; Malouf GG; Issa JJ
    Mol Cancer Ther; 2017 Feb; 16(2):397-407. PubMed ID: 27980103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl-CpG targeted transcriptional activation allows re-expression of tumor suppressor genes in human cancer cells.
    Fukushige S; Kondo E; Horii A
    Biochem Biophys Res Commun; 2008 Dec; 377(2):600-605. PubMed ID: 18929535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation.
    Pruitt K; Zinn RL; Ohm JE; McGarvey KM; Kang SH; Watkins DN; Herman JG; Baylin SB
    PLoS Genet; 2006 Mar; 2(3):e40. PubMed ID: 16596166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
    Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
    Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
    Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
    Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
    Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
    Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
    Paz MF; Wei S; Cigudosa JC; Rodriguez-Perales S; Peinado MA; Huang TH; Esteller M
    Hum Mol Genet; 2003 Sep; 12(17):2209-19. PubMed ID: 12915469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
    Teodoridis JM; Strathdee G; Brown R
    Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation associated with polycomb repression in retinoic acid receptor β silencing.
    Moison C; Senamaud-Beaufort C; Fourrière L; Champion C; Ceccaldi A; Lacomme S; Daunay A; Tost J; Arimondo PB; Guieysse-Peugeot AL
    FASEB J; 2013 Apr; 27(4):1468-78. PubMed ID: 23299856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
    Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
    Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
    Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
    Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.